Intellia Therapeutics (NTLA) Amortizatization of Intangibles (2019 - 2026)

Intellia Therapeutics (NTLA) has 8 years of Amortizatization of Intangibles data on file, last reported at $535000.0 in Q1 2026.

• On a quarterly basis, Amortizatization of Intangibles fell 76.54% year-over-year to $535000.0 in Q1 2026; TTM through Mar 2026 was $4.1 million, a 72.23% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 67.12% from the prior year.
• Amortizatization of Intangibles for Q1 2026 stood at $535000.0, down from $826000.0 in the prior quarter.
• Over the last five years, Amortizatization of Intangibles for NTLA reached as high as $7.9 million in Q3 2023 and fell as low as -$2.4 million in Q1 2022.
• Historically, Amortizatization of Intangibles has averaged $2.7 million across 5 years, with a median of $2.3 million in 2025.
• Across the five-year window, Amortizatization of Intangibles slumped 100.66% in 2022 and jumped 1061.53% in 2023, its largest moves.
• Year by year, Amortizatization of Intangibles stood at $1.2 million in 2022, then soared by 404.96% to $6.3 million in 2023, then sank by 42.89% to $3.6 million in 2024, then plunged by 77.07% to $826000.0 in 2025, then sank by 35.23% to $535000.0 in 2026.
• Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $535000.0 in Q1 2026, $826000.0 in Q4 2025, and $1.1 million in Q3 2025.